USD 5.84
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 211.47 Million USD | 7.26% |
2022 | 197.16 Million USD | 18.27% |
2021 | 166.71 Million USD | 5.21% |
2020 | 158.46 Million USD | -12.33% |
2019 | 180.74 Million USD | 18.6% |
2018 | 152.39 Million USD | 5.09% |
2017 | 145.01 Million USD | 4.98% |
2016 | 138.14 Million USD | 599.8% |
2015 | 19.74 Million USD | 1.17% |
2014 | 19.51 Million USD | 0.0% |
2013 | - USD | 0.0% |
2012 | - USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 214.76 Million USD | 1.56% |
2024 Q2 | 180.55 Million USD | -15.93% |
2023 Q1 | 196.12 Million USD | -0.53% |
2023 FY | 211.47 Million USD | 7.26% |
2023 Q3 | 193.9 Million USD | -0.58% |
2023 Q2 | 195.04 Million USD | -0.55% |
2023 Q4 | 211.47 Million USD | 9.06% |
2022 Q1 | 200.13 Million USD | 20.05% |
2022 Q2 | 199.18 Million USD | -0.48% |
2022 Q3 | 198.18 Million USD | -0.5% |
2022 Q4 | 197.16 Million USD | -0.51% |
2022 FY | 197.16 Million USD | 18.27% |
2021 Q2 | 163.84 Million USD | 2.57% |
2021 Q3 | 165.08 Million USD | 0.75% |
2021 Q4 | 166.71 Million USD | 0.99% |
2021 Q1 | 159.73 Million USD | 0.81% |
2021 FY | 166.71 Million USD | 5.21% |
2020 FY | 158.46 Million USD | -12.33% |
2020 Q3 | 157.17 Million USD | 0.77% |
2020 Q1 | 181.92 Million USD | 0.65% |
2020 Q4 | 158.46 Million USD | 0.82% |
2020 Q2 | 155.97 Million USD | -14.26% |
2019 FY | 180.74 Million USD | 18.6% |
2019 Q2 | 178.46 Million USD | 0.64% |
2019 Q3 | 179.6 Million USD | 0.64% |
2019 Q1 | 177.33 Million USD | 16.36% |
2019 Q4 | 180.74 Million USD | 0.64% |
2018 Q1 | 146.82 Million USD | 1.24% |
2018 Q3 | 150.5 Million USD | 1.25% |
2018 Q4 | 152.39 Million USD | 1.25% |
2018 FY | 152.39 Million USD | 5.09% |
2018 Q2 | 148.64 Million USD | 1.24% |
2017 Q2 | 141.52 Million USD | 1.22% |
2017 FY | 145.01 Million USD | 4.98% |
2017 Q4 | 145.01 Million USD | 1.23% |
2017 Q3 | 143.26 Million USD | 1.23% |
2017 Q1 | 139.82 Million USD | 1.22% |
2016 Q4 | 138.14 Million USD | 1.2% |
2016 Q1 | 19.8 Million USD | 0.31% |
2016 FY | 138.14 Million USD | 599.8% |
2016 Q2 | 134.78 Million USD | 580.7% |
2016 Q3 | 136.49 Million USD | 1.27% |
2015 Q1 | 19.56 Million USD | 0.3% |
2015 FY | 19.74 Million USD | 1.17% |
2015 Q2 | 19.62 Million USD | 0.3% |
2015 Q4 | 19.74 Million USD | 0.26% |
2015 Q3 | 19.68 Million USD | 0.31% |
2014 Q2 | - USD | 0.0% |
2014 Q1 | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
2014 Q4 | 19.51 Million USD | 0.0% |
2014 FY | 19.51 Million USD | 0.0% |
2013 FY | - USD | 0.0% |
2013 Q4 | - USD | 0.0% |
2013 Q1 | - USD | 0.0% |
2012 FY | - USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Abbott Laboratories | 13.59 Billion USD | 98.445% |
Allurion Technologies Inc. | 2.3 Million USD | -9070.468% |
Artivion, Inc. | 305.53 Million USD | 30.786% |
Avanos Medical, Inc. | 159.4 Million USD | -32.667% |
Butterfly Network, Inc. | 22.83 Million USD | -826.083% |
Butterfly Network, Inc. | 22.83 Million USD | -826.083% |
Bio-Rad Laboratories, Inc. | 1.18 Billion USD | 82.221% |
Boston Scientific Corporation | 8.96 Billion USD | 97.64% |
CONMED Corporation | 971.48 Million USD | 78.232% |
Edwards Lifesciences Corporation | 670 Million USD | 68.437% |
Paragon 28, Inc. | 109.79 Million USD | -92.598% |
Glaukos Corporation | 383.73 Million USD | 44.892% |
Globus Medical, Inc. | 417.4 Million USD | 49.336% |
Inspire Medical Systems, Inc. | 24.84 Million USD | -751.127% |
Integer Holdings Corporation | 959.92 Million USD | 77.97% |
Medtronic plc | 23.87 Billion USD | 99.114% |
Myomo, Inc. | 115.16 Thousand USD | -183532.338% |
Owlet, Inc. | 22 Thousand USD | -961131.818% |
Penumbra, Inc. | 220.9 Million USD | 4.272% |
Vicarious Surgical Inc. | 13.78 Million USD | -1434.066% |
Smith & Nephew plc | 2.17 Billion USD | 90.277% |
Sonendo, Inc. | 14.03 Million USD | -1406.74% |
STERIS plc | 3.12 Billion USD | 93.222% |
Stryker Corporation | 10.9 Billion USD | 98.06% |
Vapotherm, Inc. | 109.97 Million USD | -92.285% |
Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 95.656% |